1-6 of 6
Jonathan Lochner
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy of BCMA T-Cell Engagers (TCE) Vs. Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Following BCMA-Directed Therapies, Relapsed/Refractory Multiple Myeloma: The Chicken or the Egg Dilemma

Jordan Snyder, Nausheen Ahmed, Zahra Mahmoudjafari, Al-Ola Abdallah, Joseph P. McGuirk, Muhammad Umair Mushtaq, Alma Habib, Abdullah Mohammad Khan, Mehak M Laharwal, Prerna Mewawalla, Marshall McKenna, Yun Kyoung Tiger, Hira Shaikh, Andrew Vegel, Emily Struble, Jonathan Lochner, Christopher Strouse, Kimberly M Green, James A Davis, Hamza Hashmi, Shebli Atrash, Reed Friend, Barry Paul
Journal: Blood
Blood (2024) 144 (Supplement 1): 7098.
https://doi.org/10.1182/blood-2024-207398
Published: 2024
Journal Articles

Talquetamab in B Cell Maturation Antigen (BCMA) Exposed Relapsed-Refractory Multiple Myeloma Patients

Hira Shaikh, Jonathan Lochner, Bradley Loeffler, Reed Friend, Alma Habib, Marshall McKenna, Jordan Snyder, James A Davis, Gina Patrus, Rachel Dileo, Prerna Mewawalla, Kimberly M Green, Muhammad Umair Mushtaq, Christopher Strouse, Yun Kyoung Tiger, Al-Ola Abdallah, Nausheen Ahmed, Abdullah Mohammad Khan, Hamza Hashmi, Barry Paul, Shebli Atrash
Journal: Blood
Blood (2024) 144 (Supplement 1): 5170.4.
https://doi.org/10.1182/blood-2024-211018
Published: 2024
Journal Articles

Real-World Safety and Efficacy of Talquetamab for Patients with Heavily Pretreated Relapsed-Refractory Multiple Myeloma

Hira Shaikh, Jonathan Lochner, Bradley Loeffler, Reed Friend, Alma Habib, Marshall McKenna, Jordan Snyder, James A Davis, Gina Patrus, Rachel Dileo, Prerna Mewawalla, Kimberly M Green, Kittika Poonsombudlert, Muhammad Umair Mushtaq, Al-Ola Abdallah, Nausheen Ahmed, Shebli Atrash, Hamza Hashmi, Christopher Strouse, Barry Paul, Abdullah Mohammad Khan, Yun Kyoung Tiger
Journal: Blood
Blood (2024) 144 (Supplement 1): 7860.
https://doi.org/10.1182/blood-2024-210976
Published: 2024
Journal Articles

Evaluation of Teclistamab in BCMA-Directed Therapy Exposed Versus Naïve in Relapsed/Refractory Multiple Myeloma

Jordan Snyder, Kevin Graf, James A Davis, Marshall McKenna, Yun Kyoung Tiger, Mehak M Laharwal, Prerna Mewawalla, Omar Alkharabsheh, Hamza Hashmi, Hira Shaikh, Jonathan Lochner, Darryl Chang, Shebli Atrash, Alma Habib, Priyanka Venkatesh, Zahra Mahmoudjafari, Nausheen Ahmed, Muhammad Umair Mushtaq, Al-Ola Abdallah, Kimberly M Green, Abdullah Mohammad Khan
Journal: Blood
Blood (2024) 144 (Supplement 1): 2411.7.
https://doi.org/10.1182/blood-2024-204158
Published: 2024
Journal Articles

Toxicity and Efficacy Outcomes of Teclistamab in Patients with Relapsed-Refractory Multiple Myeloma (RRMM) Above the Age of 70 Years: A Multicenter Study

Danai Dima, Aishwarya Sannareddy, Nausheen Ahmed, James A Davis, Hira Shaikh, Zahra Mahmoudjafari, Marissa Duco, Jack Khouri, Gurbakhash Kaur, Jonathan Lochner, Faiz Anwer, Aimaz Afrough, Jason Valent, Hamza Hashmi, Al-Ola Abdallah
Journal: Blood
Blood (2023) 142 (Supplement 1): 3330.
https://doi.org/10.1182/blood-2023-180458
Published: 2023
Journal Articles

Clinical Outcomes of Patients Receiving 3 Versus 4 Doses of Methotrexate with Concomitant Anti-Thymocyte Globulin; A Single Center Experience

Kittika Poonsombudlert, Sarah L Mott, Brenda Miller, Hira Shaikh, Christopher Strouse, Jonathan Lochner, Umar Farooq, Margarida Magalhaes-Silverman
Journal: Blood
Blood (2023) 142 (Supplement 1): 2174.
https://doi.org/10.1182/blood-2023-181780
Published: 2023